GDC--0084, page-39

Johnny

What results are you expecting ???

Each of those phase 1 or 2 collaborations have years to complete trials - refer each institutions website and see all trial information and completion dates

The current phase 11a trial - expects some results on safety - efficacy in late 2019

Some updates on dosages phase 11a have already been released this year

Then if all goes well with safety - will enter a phase 11b - dosage range trial by mid next year - estimated cost of $15m-$20m dollars alone

Cantrixil phase 1 results expected and Edison States they expect a partner to progress to phase 2 -if results merit this

DYOR outside of HC